Purpose: To develop a simple vanadometric spectrophotometric method for the assay of timolol. Methods: The oxidation reactions were performed at optimum conditions of 3 mL 20 % v/v H2SO4, 6.5 % w/v ammonium metavanadate, 
INTRODUCTION
Transition element-based compounds have great potentials in quality control (QC) of pharmaceuticals due to the presence of lone electron pair(s), and the consequent ability to form complexes with many drugs. Ammonium metavanadate (AMV) is a yellow crystalline solid that has been used variously as a catalyst for alpha-hydroxyphosphonate [1], insulin mimic [2] , oxidizer and sensor for N-acetyltransferase activity in urine analysis post-isoniazid administration [3] and is known to exhibit pHdependent variable oxidative states of +5 to +2 due to 3d34s2 configuration of central vanadium with colour variations in solution of reductants [4] . These unique properties of AMV have been utilized in the analysis of many pharmaceutical dosage forms and inorganic cations.
Timolol maleate (Scheme 1) is a first generation non-selective beta-adrenergic receptor antagonist used in the treatment of myocardial infarction,
migraine, chronic open-angle glaucoma, heart attack, angina pectoris and ocular hypertension [5] . It is chemically designated as (S)-1-[(1, 1-dimethylethyl) amino]-3- [[4-(4-morpholinyl) -1, 2, 5-thiadiazol-3-yl] oxy]-2-propanol (Z)-2-butenedioate (1:1) salt. Timolol, in combination with a diuretic, has remained the first line drug of choice in a stepped-care approach to anti-hypertensive drug therapy and has remained among the top prescribed agents for management of cardiac disorders among the blacks.
The therapeutic importance of timolol necessitated development of spectrophotometric [6] [7] [8] [9] [10] Literature survey indicated no report(s) of developed vanadometric assay method for timolol in single or combined forms. Against this backdrop, we developed and validated an oxidometric spectrophotometric assay method for timolol, applied the developed validated method for assay of the drug in a single dosage form and compared the validation parameters with the earlier developed methods of assay. Attempts were also made to propose the possible route and mechanisms of oxidation; the principle of which the developed method is dependent.
EXPERIMENTAL Materials
Whatman 0.2 µm membrane filter, 25 mm diameter size (Cole-Palmer, Nigeria), U-2900 double beam UV-visible spectrophotometer, 190 -1100 nm, 1.5 nm spectral bandpass (Hitachi High-Tech Co, Japan). All the reagents are of analytical grade. All the timolol formulations (0.25 and 0.5 %) used were procured from reputable drug outlets and were still within their expiry date.
Methods

Optimization of experimental variables
The effect of AMV concentration was determined by adding aliquot 1.0 mL of 0.5 -10 % w/v AMV to equal volume (1 mL) of 2.5 ppm timolol in different test tubes. The nature and concentration of acidic medium (H 2 SO 4 , HCl, HNO 3 , H 3 PO 4 and HClO 3 ) were studied by adding various volumes (0.5 -6 mL) of concentrated acids and the optimum concentration of oxidant to 2.5 ppm timolol solution. Optimum temperature was determined by carrying out the reaction in a thermostatically controlled water bath at different temperatures 25 -100 ºC at the optimum conditions so far determined, while the reaction time was studied for different periods of time (0-60 mins). The stability of the developed colour was studied up to 4 h, while the order of addition of AMV, acid, and temperature to the drug solution were determined appropriately. For each variable, the rate of blue colour development and the absorbance values recorded at 504 nm were used as parameter for selecting optimum condition for the analysis.
General timolol assay method
The standard timolol solution (1 mL) was transferred into 10 mL calibrated flask and 1 mL of the 6.5 % w/v AMV was added. The optimum volume (3 mL) of 20 % v/v of H 2 SO 4 was added ( Table 1 ). The contents of the flasks were thoroughly mixed and the reactions were allowed to proceed for different periods of time (Table 1) at different temperature (40 -60 °C), and then cooled to room temperature. After completion of the reactions, the solutions were completed to volume with distilled water. The absorbance of the resulting solutions was measured at the λ max of 504 nm against reagent blanks treated similarly.
Method validation
The proposed method was validated in accordance with the ICH guidelines Q2 (R1) for linearity, precision, accuracy, limits of detection and quantization, interference, ruggedness and robustness [9] . The linearity was determined by preparing six replicates of standard solution of timolol in the range of 2-20 ppm and the construction of standard calibration curves using the optimum conditions. Regression analysis was carried out using least square method. Precision was determined by replicate analysis of nine different solutions of timolol at 10 ppm and estimating the relative standard deviation, RSD. Robustness was determined by carrying out the reaction at temperature of 40 ºC instead of 50 ºC, and then 5 % w/v AMV instead of 6.5 % w/v to ascertain the influences of AMV concentration and temperature variations (or any other parameter) on the performance of the proposed method while keeping other optimum conditions unchanged. The percentage recovery and the RSD were determined. Ruggedness was performed by carrying out the analysis on different days and using two different spectrophotometers in different laboratories. The percentage recovery and % RSD were determined for day-to-day and laboratorylaboratory assay. The limit of detection (LOD) and limit of quantitation (LOQ) were determined using the formula 3S/slope and 10S/slope respectively, where S is the standard deviation of the intercept of the Beer's calibration.
Recovery studies
Recovery studies were carried out by adding a 10 ppm solution of pre-analyzed timolol eye-drop to standard solution of pure timolol at 80, 100 and 120 % levels [6] . To 1 mL of pre-analyzed eye-drop solution in three different test tubes, 0.8, 1.0 and 1.2 mL of 10 ppm standard solution were added to each of the eye-drop solution respectively and then 1 mL AMV + 3 mL sulphuric acid. The solutions were diluted to 10 mL volume and assayed.
Analysis of timolol formulations by proposed method
A quantity of eye-drop equivalent to 1 mg of timolol was accurately measured and transferred into a 10 mL volumetric flask, appropriately diluted with 1 mL 6.5 % w/v AMV and 3 mL 20 % v/v of sulphuric acid, made up to mark with distilled water and then warmed to the required temperature and allowed some time for colour development to finally produce a sample solution for UV/VIS spectrophotometric analysis as already described. The amount of drug present in the sample solution was determined using the regression equation of calibration curve of standard [8] .
RESULTS
The preliminary findings (Table 1) showed that the absorption intensity of timolol increased progressively with increasing concentration of AMV and H 2 SO 4 , reaction time and temperature until the maximum absorbance was obtained. However, further increase in the concentration of AMV or acid, temperature or time had no effect on the absorbance.
The parameters selected as optimum conditions (Table 1) were considered as the parameter (concentration, time and temperature) at which maximum absorbance was obtained or full colour development observed in the near plateau region of the parameter-absorbance curves. 
DISCUSSION
The stability of the complex was observed beyond 3.4 h which is an indication that this assay could be done for a longer time than usual, thereby providing flexibility of the method in cases of large scale assay in QC. The order of addition was performed to determine effect sequence of inclusion of the parameters during timolol assay. The result showed that the acidic medium should be created first once the drug comes in contact with the oxidant before adjusting the time or the temperature or both.
Other acids did not provide intense colour development compared to H 2 SO 4 .
The result of method validation showed that Beer's law was obeyed at 2 -20 ppm concentration with good correlation coefficient (0.9995). The RSD was less than 2 % (0.98 %) signifying good reproducibility of the proposed method for routine timolol assay. The percentage recovery of timolol was 98 -101 % while the % RSD was 1.1 %. Variations of optimum parameters did not affect the recovery and RSD significantly showing the reliability and flexibility of the proposed method of timolol analysis. The % RSD obtained for lab-to-lab and day-to-day assay were 1.25 and 1.251 respectively showing the reproducibility of the proposed method.
Timolol is a morpholine ring-containing (A) β-adrenoceptor antagonist. Cleavage of the morpholine ring constitutes one of the major oxidation pathways, aside S-oxidation of thiadiazole ring (B) as shown in Scheme 1.
The morpholine cleavage involves two pathways-(I) initial oxidative attack on one of the carbon atoms adjacent to the nitrogen atom of the morpholine ring forming hydroxyl-ether intermediates and the timolol ethanolamine and (II) cleavage of the morpholine ring of timolol occurs prior to oxidative attack at one of the carbon atoms adjacent to the oxygen atom; The validation parameters of timolol maleate in this study compare very well with reported parameters of other developed methods, suggesting the suitability of this method in the routine assay of timolol. The UV detection ʎ differs due to the differences in the methods developed and solvents applied. Theoretically, the sensitivities of some of the earliest developed methods are higher than the present method; however, most of them are too expensive and cumbersome to be used in the routine assay of timolol especially in developing economies where their procurement, expertise and maintenance are difficult to come by. [19]
Derivative and derivative ratio spectrophotometry ʎ max 295 nm, linearity 3-20 ppm, regression equation y=0.0394x-0.002, R 2 0.99992, LOD 0.32 ppm, LOQ 0.97, precision RSD<2 %.
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